[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4014/jmb.0808.493

Efficacy of Bacteriophage Treatment in Murine Burn Wound Infection Induced by Klebsiella pneumoniae

Kumari, Seema (Department of Microbiology, Panjab University)
Harjai, Kusum (Department of Microbiology, Panjab University)
Chhibber, Sanjay (Department of Microbiology, Panjab University)

Publication Information

Journal of Microbiology and Biotechnology / v.19, no.6, 2009 , pp. 622-628 More about this Journal

Abstract

In the present study, the therapeutic potential of purified and well-characterized bacteriophages was evaluated in thermally injured mice infected with Klebsiella pneumoniae B5055. The efficacy of five Klebsiella phages (Kpn5, Kpn12, Kpn13, Kpn17, and Kpn22) was evaluated on the basis of survival rate, decrease in bacterial counts in different organs of phage-treated animals, and regeneration of skin cells as observed by histopathological examination of phage-treated skin. Toxicity studies performed with all the phages showed them to be non-toxic, as no signs of morbidity and mortality were observed in phage-treated mice. The results of the study indicate that a single dose of phages, intraperitoneally (i.p.) at an MOI of 1.0, resulted in significant decrease in mortality, and this dose was found to be sufficient to completely cure K. pneumoniae infection in the burn wound model. Maximum decrease in bacterial counts in different organs was observed at 72 h post infection. Histopathological examination of skin of phage-treated mice showed complete recovery of burn infection. Kpn5 phage was found to be highly effective among all the phages and equally effective when compared with a cocktail of all the phages. From these results, it can be concluded that phage therapy may have the potential to be used as stand-alone therapy for K. pneumoniae induced burn wound infection, especially in situations where multiple antibiotic-resistant organisms are encountered.

Keywords

Sewage samples; bacteriophages; phage therapy; bum wound infection; Klebsiella pneumoniae; histopathological examination;

Citations & Related Records

Times Cited By Web Of Science : 7 (Related Records In Web of Science)

Reference

1	Adams, M. (ed.). 1959. Bacteriophages. Interscience Publishers, London, United Kingdom
2	Bruttin, A. and H. Brussow. 2005. Human volunteers receiving Escherichia coli phage T4 orally: A safety test of phage therapy. Antimicrob. Agents Chemother. 49: 2874-2878 DOI ScienceOn
3	Capparelli, R., I. Ventimiglia, S. Roperto, D. Fenizia, and D. Iannelli. 2006. Selection of an Escherichia coli O157:H7 bacteriophage for persistence in the circulatory system of mice infected experimentally. Clin. Microbiol. Infect. 12: 248-253 DOI ScienceOn
4	Cryz, S. J. Jr., E. Furer, and R. Germanier. 1984. Experimental Klebsiella pneumoniae burn wound sepsis: Role of capsular polysaccharide. Infect. Immun. 43:440-441 PUBMED
5	Inal, J. M. 2003. Phage therapy: A reappraisal of bacteriophages as antibiotics. Arch. Immunol. Ther. Exp. (Warsaw) 51: 237-244
6	Merril, C. R., B. Biswas, R. Carlon, N. C. Jensen, G. J. Creed, S. Zullo, and S. Adhya. 1996. Long-circulating bacteriophage as antibacterial agents. Proc. Natl. Acad. Sci. U.S.A. 93: 3188-3192 DOI ScienceOn
7	Rumbaugh, K. P., J. A. Griswold, B. H. Iglewski, and A. N. Hamood. 1999. Contribution of quorum sensing to the virulence of Pseudomonas aeruginosa in burn wound infections. Infect. Immun. 67: 5854-5862 PUBMED
8	Theil, K. 2004. Old dogma, new tricks - 21st century phage therapy. Nat. Biotechnol. 22: 31-36 DOI PUBMED ScienceOn
9	Signori, M., S. Grappolini, E. Magliano, and L. Donati. 1992. Updated evaluation of the activity of antibiotics in a burn center. Burns 18: 500-503 DOI ScienceOn
10	Wills, Q. F., C. Kerrigan, and J. A. Soothill. 2005. Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model. Antimicrob. Agents Chemother. 49: 1220-1221 DOI ScienceOn
11	Ozumba, U. C. and B. C. Jiburum. 2000. Bacteriology of burn wounds in Enugu, Nigeria. Burns 26: 178-180 DOI ScienceOn
12	Cerveny, K. E., A. DePaola, D. H. Duckworth, and P. A. Gulig. 2002. Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice. Infect. Immun. 70: 6251-6262 DOI ScienceOn
13	Smith, H. W. and M. B. Huggins. 1982. Successful treatment of experimental Escherichia coli infections in mice using phages:Its general superiority over antibiotics. J. Gen. Microbiol. 128:307-318 PUBMED ScienceOn
14	Danelishvili, L., L. S. Young, and L. E. Bermudez. 2006. In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent Mycobacterium. Microb. Drug Resist. 12: 1-6 DOI ScienceOn
15	Weber-Dabrowska, B., M. Zimecki, and M. Mulczyk. 2000. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures. Arch. Immunol. Ther. Exp. 48: 31-37 PUBMED
16	Dale, R. M., K. G. Schnell, and J. P. Wong. 2004. Therapeutic efficacy of 'Nubiotics' against burn wound infection by Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48:2918-2923 DOI ScienceOn
17	Kehinde, A. O., S. A. Ademola, A. O. Okesola, O. M. Oluwatosin, and R. Bakare. 2004. Pattern of bacterial pathogens in burn wound infections in Ibadan, Nigeria. Ann. Burns Fire Disast. 17: 12-15
18	Matsuzaki, S., M. Yasuda, H. Nishikawa, M. Kuroda, T. Ujihara, T. Shuin, et al. 2003. Experimental protection of mice against lethal Staphylococcus aureus infection by novel bacteriophage $\phi$ MR11. J. Infect. Dis. 187: 613-624 DOI ScienceOn
19	Loc Carrillo, C. L., R. D. J. Atterbury, A. El-Shibiny, P. L. Connerton, E. Dillon, A. Scott, and I. F. Connerton. 2005. Bacteriophage therapy to reduce Campylobacter jejuni colonization of broiler chickens. Appl. Environ. Microbiol. 71: 6554-6563 DOI PUBMED ScienceOn
20	Sulakvelidze, A., Z. Alavidze, and J. G. Morris Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659 DOI ScienceOn
21	McVay, C., S. M. Velasquez, and J. A. Fralick. 2007. Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob. Agents Chemother. 51: 1934-1938 DOI ScienceOn
22	Church, D., S. Elsayed, O. Reid, B. Winston, and R. Lindsay. 2006. Burn wound infections. Clin. Microbiol. Rev. 19: 403-434 DOI ScienceOn
23	Nasser, S., A. Mabrouk, and A. Maher. 2003. Colonization of burn wounds in Ain Shams University Burn Unit. Burns 29:229-233 DOI ScienceOn
24	Paissano, A. F., B. Spira, S. Cai, and A. C. Bombana. 2004. In vitro antimicrobial effects of bacteriophages on human dentin infected with Enterococcus faecalis ATCC 29212. Oral Microbiol. Immunol. 19: 327-330 DOI ScienceOn
25	Casewell, M. W. and I. Phillips. 1981. Aspects of the plasmid mediated antibiotic resistance and epidemiology of Klebsiella species. Am. J. Med. 70: 459-462 DOI ScienceOn
26	Ioseliani, G. D., G. D. Meladze, N. S. Chkhetiia, M. G. Mebuke, and N. I. Kiknadze. 1980. Use of bacteriophage and antibiotics for prevention of acute postoperative empyema in chronic suppurative lung diseases. Grudn. Khir. 6: 63-67
27	Stroj, L., B. Weber-Dabrowska, K. Partyka, M. Mulczyk, and M. Wojcik. 1999. Successful treatment with bacteriophage in purulent cerebrospinal meningitis in a newborn. Neurol. Neurochir. Pol. 3: 693-698
28	Levin, B. and J. J. Bull. 1996. Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 147: 881-898 DOI ScienceOn
29	Wang, J., B. Hu, M. Xu, Q. Yan, S. Liu, X. Zhu, ei al. 2006. Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa. Int. J. Mol. Med. 17: 309-317 PUBMED
30	Schembri, M. A., J. Blom, A. K. Krogfelt, and P. Klemm. 2005. Capsule and fimbria interaction in Klebsiella pneumoniae. Infect. Immun. 73: 4626-4633 DOI ScienceOn
31	Benedict, L. R. N. and R. S. Flamiano. 2004. Use of bacteriophages as therapy for Escherichia coli-induced bacteremia in mouse models. Phil. J. Microbiol. Infect. Dis. 33: 47-51
32	Biswas, B., S. Adhya, P. Washart, B. Paul, A. N. Trostel, B. Powell, R. Carlton, and C. R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70:204-210 DOI ScienceOn
33	Matsuzaki, S., M. Rashel, J. Uchiyma, T. Ujihara, M. Kuroda, M. Ikeuchi, M. Fujieda, J. Wakiguchi, and S. Imai. 2005. Bacteriophage therapy: A revitalized therapy against bacterial infectious diseases. J. Infect. Chemother. 11: 211-219 DOI ScienceOn
34	Lorch, A. 1999. Bacteriophages: An alternative to antibiotics? Biotech. Develop. Monitor 39: 14-17
35	Brans, T. A., R. P. Dutrieux, M. J. Hoekstra, R. W. Kreis, and J. S. du Pont 1994. Histopathological evaluation of scalds and contact burns in the pig model. Burns 20: 548-551

Reference

3	(2009) Current microbiology Characterization of a T7-Like Lytic Bacteriophage of Klebsiella pneumoniae B5055: A Potential Therapeutic Agent / 59 (3) , 274
5	(2009) Journal of microbiology and biotechnology Evidence to Support the Therapeutic Potential of Bacteriophage Kpn5 in Burn Wound Infection Caused by Klebsiella pneumoniae in BALB/c Mice / 20 (5) , 935
2	(2011) Journal of medical microbiology Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055 / 60 (2) , 205
None	(2009) Frontiers in cellular and infection microbiology The Promise of Bacteriophage Therapy for <I>Burkholderia cepacia</I> Complex Respiratory Infections / 1 (None) , 27
4	(2009) Applied microbiology and biotechnology Isolation and characterisation of KP34—a novel φKMV-like bacteriophage for <I>Klebsiella pneumoniae</I> / 90 (4) , 1333
1	(2009) Virology journal Characterising the biology of novel lytic bacteriophages infecting multidrug resistant <I>Klebsiella pneumoniae</I> / 10 (1) , 100
6	(2009) Future microbiology Phage cocktails and the future of phage therapy / 8 (6) , 769
4	(2009) PLoS ONE <I>Klebsiella</I> Phage vB_KleM-RaK2 — A Giant Singleton Virus of the Family <I>Myoviridae</I> / 8 (4) , e60717
10	(2014) Applied microbiology and biotechnology Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages / 98 (10) , 4653
1	(2014) The Journal of infectious diseases : official publication of the Infectious Diseases Society of America Bacteriophage Therapy of a <I>Vibrio parahaemolyticus</I> Infection Caused by a Multiple-Antibiotic–Resistant O3:K6 Pandemic Clinical Strain / 210 (1) , 72
None	(2009) PeerJ <I>Klebsiella pneumoniae</I> subsp. <I>pneumoniae</I> –bacteriophage combination from the caecal effluent of a healthy woman / 3 (None) , e1061
10	(2009) Journal of drug targeting Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive<I>Staphylococcus aureus</I>(MSSA) involved burn wound infection / 23 (10) , 943
10	(2009) Cold Spring Harbor perspectives in biology Phage Therapy in the Era of Synthetic Biology / 8 (10) , a023879
8	(2017) Expert opinion on pharmacotherapy Treatment options for diabetic foot osteomyelitis / 18 (8) , 759
None	(2009) Frontiers in cellular and infection microbiology Development of a High-Throughput <I>ex-Vivo</I> Burn Wound Model Using Porcine Skin, and Its Application to Evaluate New Approaches to Control Wound Infection / 8 (None) , 196
None	(2009) Frontiers in microbiology Liposome Entrapment of Bacteriophages Improves Wound Healing in a Diabetic Mouse MRSA Infection / 9 (None) , 561
None	(2018) Frontiers in microbiology Prevention of Dermal Abscess Formation Caused by <I>Staphylococcus aureus</I> Using Phage JD007 in Nude Mice / 9 (None) , 1553
None	(2009) BioMed research international Kinetics of Targeted Phage Rescue in a Mouse Model of Systemic <I> Escherichia coli</I> K1 / 2018 (None) , 7569645
12	(2009) Expert review of anti-infective therapy Biological challenges of phage therapy and proposed solutions: a literature review / 17 (12) , 1011
None	(2020) Drug design, development and therapy Bacteriophages, a New Therapeutic Solution for Inhibiting Multidrug-Resistant Bacteria Causing Wound Infection: Lesson from Animal Models and Clinical Trials / 14 (None) , 1867
2	(2009) Journal of medical microbiology Bacteriophages of <I>Klebsiella</I> spp., their diversity and potential therapeutic uses / 69 (2) , 176
1	(2020) EcoSal Plus Bacteriophage Infections of Biofilms of Health Care-Associated Pathogens: <I>Klebsiella pneumoniae</I> / 9 (1) , ecosalplus.ESP-0029-2019
6	(2009) Microorganisms Isolation and Characterization of Two Bacteriophages and Their Preventive Effects against Pathogenic Vibrio coralliilyticus Causing Mortality of Pacific Oyster ( Crassostrea gigas ) Larvae / 8 (6) , 926
3	(2009) Sovremennye tekhnologii v medi&n.tlligat;&n.srligat;ine Application of Phagotherapy in the Treatment of Burn Patients (Review) / 12 (3) , 95
6	(2009) Journal of applied microbiology Use of bacteriophage vB_Pd_PDCC‐1 as biological control agent of <I>Photobacterium damselae</I> subsp. <I>damselae</I> during hatching of longfin yellowtail (<I>Seriola rivoliana</I>) eggs / 129 (6) , 1497
None	(2021) Frontiers in pharmacology Nanotechnology Based Approaches in Phage Therapy: Overcoming the Pharmacological Barriers / 12 (None) , 699054
None	(2021) Frontiers in cellular and infection microbiology Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections / 11 (None) , 758392
4	(2009) Cellular & molecular immunology Phages and their potential to modulate the microbiome and immunity / 18 (4) , 889
6	(2009) Folia microbiologica A mouse air pouch model for evaluating the anti-bacterial efficacy of phage MR-5 in resolving skin and soft tissue infection induced by methicillin-resistant Staphylococcus aureus / 66 (6) , 959